Exact Mass: 404.080846
Exact Mass Matches: 404.080846
Found 332 metabolites which its exact mass value is equals to given mass value 404.080846,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
3-O-(3,6-Anhydro-alpha-D-galactopyranosyl)-D-galactose 4-O-sulfate
C12H20O13S (404.06245900000005)
Sulfinpyrazone
Sulfinpyrazone is only found in individuals that have used or taken this drug. It is a uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. [PubChem]Sulfinpyrazone is an oral uricosuric agent (pyrazolone derivative) used to treat chronic or intermittent gouty arthritis. Sulfinpyrazone competitively inhibits the reabsorption of uric acid at the proximal convoluted tubule, thereby facilitating urinary excretion of uric acid and decreasing plasma urate concentrations. This is likely done through inhibition of the urate anion transporter (hURAT1) as well as the human organic anion transporter 4 (hOAT4). Sulfinpyrazone is not intended for the treatment of acute attacks because it lacks therapeutically useful analgesic and anti-inflammatory effects. Sulfinpyrazone and its sulfide metabolite possess COX inhibitory effects. Sulfinpyrazone has also been shown to be a UDP-glucuronsyltransferase inhibitor and a very potent CYP2C9 inhibitor. Sulfinpyrazone is also known to be a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor as well as an inhibitor of several multridrug resistance proteins (MRPs). M - Musculo-skeletal system > M04 - Antigout preparations > M04A - Antigout preparations > M04AB - Preparations increasing uric acid excretion D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents C26170 - Protective Agent > C921 - Uricosuric Agent
Citalopram hydrobromide
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators
Glycerol tribenzoate
Glycerol tribenzoate is a flavouring ingredien Flavouring ingredient
Cassiaside
Isolated from seeds of Cassia tora (charota). Cassiaside is found in coffee and coffee products, herbs and spices, and pulses. Cassiaside is found in coffee and coffee products. Cassiaside is isolated from seeds of Cassia tora (charota).
Mollicellin D
C21H21ClO6 (404.10265960000004)
Mollicellin D is produced by Chaetomium species and mycotoxin. Production by Chaetomium subspecies and mycotoxin.
Urolithin A-3-O-glucuronide
Urolithin A glucuronide is a biomarker of nut consumption in urine.
Glyceryl lactopalmitate
Glyceryl lactopalmitate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")
cis-Resveratrol 3-O-glucuronide
cis-Resveratrol 3-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
cis-Resveratrol 4'-O-glucuronide
cis-Resveratrol 4-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
trans-Resveratrol 3-O-glucuronide
trans-Resveratrol 3-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
trans-Resveratrol 4'-O-glucuronide
trans-Resveratrol 4-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Urolithin A-8-O-glucuronide
Urolithin A-8-O-glucuronide is a conjugate of Urolithin A and glucuronide. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. Glucuronidation, the conversion of chemical compounds to glucuronides, is a method that animals use to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Enzymes that cleave the glycosidic bond of a glucuronide are called glucuronidases. (Wikipedia)
Zopiclone N-oxide
Zopiclone N-oxide is a primary, active metabolite of zopiclone. Zopiclone (brand names Imovane, Zimovane, and Dopareel) is a nonbenzodiazepine hypnotic agent used in the treatment of insomnia. Zopiclone is molecularly distinct from benzodiazepine drugs and belongs to the class of drugs known as cyclopyrrolones. However, zopiclone increases the normal transmission of the neurotransmitter gamma-aminobutyric acid (GABA) in the central nervous system, via modulating benzodiazepine receptors in the same way that benzodiazepine drugs do (Wikipedia).
Urolithin a 3-glucuronide
Urolithin a 8-glucuronide
Disuccinimido dithiobispropionate
C14H16N2O8S2 (404.03480559999997)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents
1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione
Iolopride
C15H21IN2O3 (404.05968659999996)
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists
Ipragliflozin
C21H21FO5S (404.10936680000003)
Chembl4483049
C20H24N2O3S2 (404.12282739999995)
Dithio bis(succinimidyl propionate)
C14H16N2O8S2 (404.03480559999997)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents
VX-702
C19H12F4N4O2 (404.08963399999993)
Calomelanol B
OC=1C=C(C=C2C(=CC(C(C=12)=O)=C1C(C2=C(C=C(C=C2C(=C1)OC)C)O)=O)OC)C
5-hydroxy-2-(5-hydroxy-4-methoxy-7-methyl-1-oxonaphthalen-2-ylidene)-4-methoxy-7-methylnaphthalen-1-one
Gardenin C
Gardenin C is a natural product found in Tamarix dioica and Murraya paniculata with data available.
3-Methoxycalycopterin
5,3-dihydroxy-3,6,7,8,4-pentamethoxyflavone
3,5-Dihydroxy-6,7,8,3,4-pentamethoxyflavone
5,4-Dihydroxy-6,7,8,3,5-pentamethoxyflavone
5,7-Dihydroxy-3,6,8,3,4-pentamethoxyflavone
2,2-Dihydroxy-3,4,5,6-tetramethoxy-3,4-methylenedioxychalcone
2-{[4-methyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-(4-sulfamoylphenyl)acetamide
N-{4-[(2,6-dimethoxypyrimidin-4-yl)sulfamoyl]phenyl}furan-2-carboxamide
Tosufloxacin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic
2,4-dihydroxy-5,6,7,8,5-pentamethoxyflavone|Agehoustin F
3-Formyl-6-(3-formyl-2,4-dihydroxy-6-methyl-benzoyloxymethyl)-2,4-dihydroxy-benzoesaeure-methylester|3-formyl-6-(3-formyl-2,4-dihydroxy-6-methyl-benzoyloxymethyl)-2,4-dihydroxy-benzoic acid methyl ester|methyl barbatolate
5,7-dihydroxy-2-(2,3,4,5,6-pentamethoxyphenyl)chromen-4-one
2-Hydroxy-6-methylbenzoic acid 4-(4-oxo-5,7-dihydroxy-4H-1-benzopyran-3-yl)phenyl ester
Integrastatin A
An organic heterotetracyclic compound that is 6H-6,12-epoxydibenzo[b,f]oxocin-11(12H)-one substituted by hydroxy groups at positions 4, 7 and 8, a hydroxymethyl group position 1, methyl groups at positions 6 and 12 and methoxy groups at positions 3 and 9. It is isolated as a racemate from Unidentified fungi (New mexico) and has been shown to exhibit inhibitory activity against HIV-1 integrase.
3,4-dihydro-7-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-2H-1-benzopyran-2-one|gnetumontanin G
5-hydroxy-8-methoxy-2-methyl-6-(alpha-D-ribofuranosyloxy)-4H-naphtho[2,3-b]pyran-4-one|6-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yloxy]-5-hydroxy-8-methoxy-2-methyl-4H-naphtho[2,3-b]pyran-4-one|rubrofusarin-6-O-alpha-D-ribofuranoside
8-acetyl-5-hydroxy-6-(3-methylbutanoyl)-4-phenyl-2H-furo[2,3-h]chromen-2-one
2,2-dihydroxy-3,4,5,6-tetramethoxy-4,5-methylenedioxychalcone
2-(3,5-dihydroxyphenyl)benzofuran-6-yl beta-D-glucopyranoside|moracin M 6 (beta-D-glucopyranoside)
3-C-beta-D-glucopyranosyl-1-hydroxy-7-methoxyxanthone
CP-114271
CONFIDENCE standard compound; INTERNAL_ID 265; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3461; ORIGINAL_PRECURSOR_SCAN_NO 3459 CONFIDENCE standard compound; INTERNAL_ID 265; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3459; ORIGINAL_PRECURSOR_SCAN_NO 3456 CONFIDENCE standard compound; INTERNAL_ID 265; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3469; ORIGINAL_PRECURSOR_SCAN_NO 3467 CONFIDENCE standard compound; INTERNAL_ID 265; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3454; ORIGINAL_PRECURSOR_SCAN_NO 3452 CONFIDENCE standard compound; INTERNAL_ID 265; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3530; ORIGINAL_PRECURSOR_SCAN_NO 3529 CONFIDENCE standard compound; INTERNAL_ID 265; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3463; ORIGINAL_PRECURSOR_SCAN_NO 3461 CONFIDENCE standard compound; INTERNAL_ID 265; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7200; ORIGINAL_PRECURSOR_SCAN_NO 7197 CONFIDENCE standard compound; INTERNAL_ID 265; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7214; ORIGINAL_PRECURSOR_SCAN_NO 7212 CONFIDENCE standard compound; INTERNAL_ID 265; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7239; ORIGINAL_PRECURSOR_SCAN_NO 7236 CONFIDENCE standard compound; INTERNAL_ID 265; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7248; ORIGINAL_PRECURSOR_SCAN_NO 7245 CONFIDENCE standard compound; INTERNAL_ID 265; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7237; ORIGINAL_PRECURSOR_SCAN_NO 7235 CONFIDENCE standard compound; INTERNAL_ID 265; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7250; ORIGINAL_PRECURSOR_SCAN_NO 7248
5,7-dihydroxy-3,6-dimethoxy-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one
Met-Phe-OH
C19H20N2O6S (404.10420200000004)
Asp-Tyr-OH
C18H16N2O9 (404.08557659999997)
Phe-Met-OH
C19H20N2O6S (404.10420200000004)
Urolithin a-O-glucuronide
Glyceryl lactopalmitate
Mollicellin D
C21H21ClO6 (404.10265960000004)
Cassiaside A
cis-Resveratrol 3-O-glucuronide
A stilbenol that is cis-resveratrol attached to a beta-D-glucopyranosiduronic acid residue at position 3 via a glycosidic linkage.
cis-Resveratrol 4'-O-glucuronide
trans-Resveratrol 3-O-glucuronide
trans-Resveratrol 4'-O-glucuronide
N-(3-Chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4-quinazolinamine
C18H14ClFN4O4 (404.06875660000003)
2,2-[1,4-phenylenebis (carbonylimino)] bis-Benzoic acid
2-[(4-chloro-2-nitrophenyl)azo]-N-(4-ethoxyphenyl)-3-oxobutyramide
tert-Butyl 3-((3-iodopyridin-2-yloxy)methyl)-pyrrolidine-1-carboxylate
C15H21IN2O3 (404.05968659999996)
3-(METHOXYCARBONYL)-5-(((4-NITROBENZYL)OXY)CARBONYL)-4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE-2-CARBOXYLIC ACID
bis[(2-hydroxyethyl)(2-hydroxyphenyl)ammonium] sulphate
7-Amino-3 chloromethyl-3-cephem-4-carboxylic Acid p-Methoxybenzyl Ester Hydrochloride
C16H18Cl2N2O4S (404.03642880000007)
1-(2,4-difluorophenyl)-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid
(Z)-4-hydroxypent-3-en-2-one,(E)-4-hydroxypent-3-en-2-one,yttrium,hydrate
Ipragliflozin
C21H21FO5S (404.10936680000003)
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BK - Sodium-glucose co-transporter 2 (sglt2) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent D007004 - Hypoglycemic Agents > D000077203 - Sodium-Glucose Transporter 2 Inhibitors C471 - Enzyme Inhibitor > C98083 - SGLT2 Inhibitor
6-BROMO-4-(2-(6-METHYLPYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOL-3-YL)QUINOLINE
7-BROMO-4-(2-(6-METHYLPYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOL-3-YL)QUINOLINE
1-Acetyl-3-(acetyloxy)-7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
3-(1H,1H-Nonafluoropentyl)-4-methylcyclopentane-1,1-dicarboxylic acid
9-fluorenylmethyl n-(5-aminopentyl)carbamate hydrobromide
C20H25BrN2O2 (404.10992899999997)
Spectinomycin dihydrochloride
A hydrochloride obtained by combining spectinomycin with two molar equivalents of hydrochloric acid. An antibiotic that is active against gram-negative bacteria and used (as its pentahydrate) to treat gonorrhea. C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Spectinomycin dihydrochloride is a broad-spectrum antibiotic and inhibits the growth of a variety of gram-positive and gram-negative organisms. Spectinomycin dihydrochloride acts by selectively targeting to the bacterial ribosome and interrupting protein synthesis. Spectinomycin dihydrochloride is also a noncompetitive inhibitor of td intron RNA with an Ki value of 7.2 mM[1]-[5].
2-(Bromomethyl)-4-fluoro-5-isopropyl-2-Methoxy-4-(trifluoromethyl)biphenyl
Sodium 7-(1H-tetrazol-1-yl)acetamidocephalosporanate
C13H13N6NaO6S (404.05149580000005)
TERT-BUTYL 4-((4-BROMOPHENYL)SULFONYL)PIPERAZINE-1-CARBOXYLATE
C15H21BrN2O4S (404.04053260000006)
Acetic acid, (4-((2R)-2-(((2S)-2-hydroxy-2-(2-(trifluoromethyl)-4-thiazolyl)ethyl)amino)propyl)phenoxy)-
(E)-3-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(1,3-benzothiazol-2-yl)prop-2-enenitrile
N-(4-acetylphenyl)-2-[[3-(2-pyridinyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]thio]acetamide
N-(3-methyl-6-methylsulfonyl-1,3-benzothiazol-2-ylidene)-2,3-dihydro-1,4-benzodioxin-6-carboxamide
(1R)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile hydrobromide
5-(Aminomethyl)-6-(2,4-dichlorophenyl)-2-(3,5-dimethoxyphenyl)pyrimidin-4-amine
{5-(5-Amino-1H-pyrrolo[3,2-B]pyridin-2-YL)-6-hydroxy-3-nitro-biphenyl-3-YL]-acetic acid
(3z)-1-[(6-Fluoro-4h-1,3-Benzodioxin-8-Yl)methyl]-4-Phenyl-1h-Indole-2,3-Dione 3-Oxime
(2r)-2-Amino-3,3,3-Trifluoro-N-Hydroxy-2-{[(4-Phenoxyphenyl)sulfonyl]methyl}propanamide
C16H15F3N2O5S (404.06537360000004)
N-[2-(4-Carboxymethoxyphenyl)-1-methylethyl]-2-hydroxy-2-(2-trifluoromethyl-thiazol-4-yl)ethanamine
3-O-(3,6-Anhydro-alpha-D-galactopyranosyl)-beta-D-galactopyranose 4-sulfate
C12H20O13S (404.06245900000005)
3-glycyl-AMP
C12H17N6O8P (404.08454520000004)
A glycinyl ester obtained by formal condensation of the carboxy group of glycinne with the 3-hydroxy group of AMP.
7-[[[1-(3-Methylphenyl)-2-benzimidazolyl]thio]methyl]-5-thiazolo[3,2-a]pyrimidinone
C21H16N4OS2 (404.07654859999997)
2-(2-Fluorophenyl)-4-(4-fluorophenyl)sulfonyl-5-(1-piperidinyl)oxazole
1-(2-Fluorophenyl)-3-[[2-oxo-1-(phenylmethyl)-3-indolylidene]amino]thiourea
N-(2,4-dimethoxyphenyl)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]butanediamide
C15H15F3N4O4S (404.07660660000005)
2-(2-fluorophenoxy)-N-[4-(2-furanylmethylsulfamoyl)phenyl]acetamide
C19H17FN2O5S (404.08421640000006)
N-(4-bromophenyl)-4-(2-methoxyphenyl)-1-piperidinecarbothioamide
C19H21BrN2OS (404.05578760000003)
2-[4-(4-Chlorophenyl)sulfonyl-1-piperazinyl]-1-ethylbenzimidazole
C19H21ClN4O2S (404.10736760000003)
N-[(4-nitrophenyl)methylene]-2-(10H-phenothiazin-10-yl)acetohydrazide
(6R)-6-(4-bromophenyl)-3-(2-furanylmethyl)-4-methyl-2-oxo-1,6-dihydropyrimidine-5-carboxylic acid methyl ester
N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-(4-methylpiperidin-1-yl)acetamide
C21H22Cl2N2O2 (404.10582519999997)
gammaGluCys(IAN)
C18H20N4O5S (404.11543500000005)
An S-conjugate dipeptide consisting of L-gamma-glutamyl-L-cysteine in which the the cysteine side chain is substituted by a cyano(indol-3-yl)methyl group.
[(3aS,4S,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-fluorophenyl)methanone
C19H18BrFN2O2 (404.05355999999995)
[(3aR,4R,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-fluorophenyl)methanone
C19H18BrFN2O2 (404.05355999999995)
[(3aS,4R,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-fluorophenyl)methanone
C19H18BrFN2O2 (404.05355999999995)
(2-fluorophenyl)-[(2S,3S)-2-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone
C20H21FN2O4S (404.12059980000004)
[(3aR,4S,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-fluorophenyl)methanone
C19H18BrFN2O2 (404.05355999999995)
(2-fluorophenyl)-[(2S,3R)-2-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone
C20H21FN2O4S (404.12059980000004)
(2-fluorophenyl)-[(2R,3R)-2-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]methanone
C20H21FN2O4S (404.12059980000004)
1-S-[3-hydroxy-3-methyl-N-(sulfonatooxy)pentanimidoyl]-1-thio-beta-D-glucopyranose
4-[2-(3-Hydroxyphenyl)sulfanylethyl]-1,2-diphenylpyrazolidine-3,5-dione
(5E)-2-Amino-5-[[3-(4-ethoxy-3-methylphenyl)-1-phenylpyrazol-4-yl]methylidene]-1,3-thiazol-4-one
3,4,5-Trihydroxy-6-[2-(1-hydroxy-2-oxo-2-phenylethyl)phenoxy]oxane-2-carboxylic acid
(4S)-1-(4-hydroxyphenyl)-2-phenyl-4-(2-phenylsulfanylethyl)pyrazolidine-3,5-dione
5,7-Dihydroxy-3,6-dimethoxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one
2-Methyl-1,4-bis(trimethylstannyl)-2-butene
C11H32Sn2 (404.05478519999997)
[2-Hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] butanoate
sulfinpyrazone
M - Musculo-skeletal system > M04 - Antigout preparations > M04A - Antigout preparations > M04AB - Preparations increasing uric acid excretion D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents C26170 - Protective Agent > C921 - Uricosuric Agent
urolithin A 3-O-glucuronide
A member of the class of benzochromenones that is urolithin A in which the phenolic hydrogen at position 3 has been replaced by a beta-D-glucuronosyl group.
urolithin A 8-O-glucuronide
A member of the class of benzochromenones that is urolithin A in which the phenolic hydrogen at position 8 has been replaced by a beta-D-glucuronosyl group.
glucocleomin(1-)
A hydroxy-alkylglucosinolate that is 2-methylbutylglucosinolate which has been hydroxylated at the 2-position of the 2-methylbutyl chain.
Leramistat
Leramistat (HMC-C-01-A; MBS2320) is a mitochondrial complex 1 inhibitor, involving in cell metabolism immune metabolism regulation. Leramistat also inhibits ATP production in Thp1 human monocytes (IC50: 0.63 μM). Leramistat inhibits atopic dermatitis and other skin diseases autoimmune diseases, inflammatory diseases, cancer; and also inhibits osteoclast mediated disease[1][2][3].
methyl 8-(2,4-dihydroxy-6-methylbenzoyloxy)-7-hydroxy-7-methyl-6-oxo-8,8a-dihydro-1h-isochromene-3-carboxylate
1',5-dihydroxy-6'-methoxy-3',7-dimethyl-[2,2'-binaphthalene]-1,4,5',8'-tetrone
5-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-6,7,8-trimethoxychromen-4-one
(2r,3r)-6-chloro-3-(4-hydroxy-3-methoxyphenyl)-5-methoxy-2-methyl-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one
5,5'-dihydroxy-4,4'-dimethoxy-7,7'-dimethyl-[2,2'-binaphthalenylidene]-1,1'-dione
2-(3,4-dimethoxyphenyl)-5,7-dihydroxy-3,6,8-trimethoxychromen-4-one
5,13,17-trihydroxy-12-(hydroxymethyl)-4-(methoxymethyl)-7-methyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3(8),4,6,12,14(18)-hexaene-9,15-dione
methyl 3,5-dimethoxy-2-{4-methoxy-5-oxo-3-[(1e)-prop-1-en-1-yl]-2,7-dioxabicyclo[4.1.0]hept-3-ene-6-carbonyl}benzoate
3-{[(5,7-dihydroxy-6-methyl-1-oxo-3h-2-benzofuran-4-yl)oxy]carbonyl}-2-hydroxy-6-methoxy-4-methylbenzoic acid
6-hydroxy-2-(2-hydroxy-4,5-dimethoxyphenyl)-3,5,7-trimethoxychromen-4-one
methyl (6r,12r,14r)-4,6,14-trihydroxy-2,12,13,13-tetramethyl-8,15-dioxo-7,11-dioxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadeca-1,3,5(16),9-tetraene-6-carboxylate
6-hydroxy-5,7,12,13,14-pentamethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione
2-[3-hydroxy-5-(6-hydroxy-1-benzofuran-2-yl)phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
16,17-dimethoxy-21-methylidene-6-(prop-1-en-2-yl)-2,7,20-trioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),3,8,10,14,16,18-heptaen-12-one
(2s)-2,4,5,7,9-pentahydroxy-8-methoxy-6-methyl-2-(2-methyl-3-oxobutan-2-yl)phenalene-1,3-dione
1-methoxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
1',4-dihydroxy-6'-methoxy-2,3'-dimethyl-[1,2'-binaphthalene]-5,5',8,8'-tetrone
3',5'-dihydroxy-3,4',5',6,7-pentamethoxy flavone
{"Ingredient_id": "HBIN007615","Ingredient_name": "3',5'-dihydroxy-3,4',5',6,7-pentamethoxy flavone","Alias": "NA","Ingredient_formula": "C20H20O9","Ingredient_Smile": "COC1=CC(=CC(=C1OC)O)C2=C(C(=O)C3=C(C(=C(C=C3O2)O)OC)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25884","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,7-dihydroxy-2',3',4',5 ',6'-pentamethoxyflavone
{"Ingredient_id": "HBIN011254","Ingredient_name": "5,7-dihydroxy-2',3',4',5 ',6'-pentamethoxyflavone","Alias": "NA","Ingredient_formula": "C20H20O9","Ingredient_Smile": "COC1=C(C(=C(C(=C1OC)OC)OC)OC)C2=CC(=O)C3=C(C=C(C=C3O2)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6071","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-5-hydroxy-8-methoxy-2-methylbenzo[g]chromen-4-one
methyl (7s,8s,8as)-8-(2,4-dihydroxy-6-methylbenzoyloxy)-7-hydroxy-7-methyl-6-oxo-8,8a-dihydro-1h-isochromene-3-carboxylate
7-chloro-3-[(6-chloro-4-hydroxy-1h-indol-3-yl)methyl]-5-hydroxy-6-methyl-3h-1,4-benzoxazepin-2-one
(2s,3r,4s,5s,6r)-2-[(5,7-dichloro-8-hydroxy-6-methylnaphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(4s)-5,7-dihydroxy-4-(4-hydroxyphenyl)-8-(3-phenylpropanoyl)-3,4-dihydro-1-benzopyran-2-one
(4r)-7-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-5-[(1e)-2-(4-hydroxyphenyl)ethenyl]-3,4-dihydro-1-benzopyran-2-one
(4r)-5,7-dihydroxy-4-(4-hydroxyphenyl)-8-(3-phenylpropanoyl)-3,4-dihydro-1-benzopyran-2-one
2,4,5,7,9-pentahydroxy-8-methoxy-6-methyl-2-(2-methyl-3-oxobutan-2-yl)phenalene-1,3-dione
2-{[2-(3,5-dihydroxyphenyl)-1-benzofuran-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
5-hydroxy-2-(4-hydroxyphenyl)-7-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
2-[(5,7-dichloro-8-hydroxy-6-methylnaphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2,5-dihydroxy-4,8'-dimethoxy-3',7-dimethyl-[1,2'-binaphthalene]-1',4'-dione
1-[(2-hydroxyphenazin-1-yl)methyl]phenazin-2-ol
C25H16N4O2 (404.12731959999996)
(2r,5'r,7s,7as)-5'-[(2-hydroxyphenyl)methyl]-5'-(methylsulfanyl)-7,7a-dihydro-3h-spiro[1-benzothiophene-2,2'-pyrazine]-3',6',7-triol
C19H20N2O4S2 (404.08644400000003)
(2e)-2,3-bis(7-methoxy-2-oxochromen-8-yl)prop-2-enal
2-(3-ethenyl-2-methyloxiran-2-yl)-11-hydroxy-5-(hydroxymethyl)-1-oxatetraphene-4,7,12-trione
methyl 3-formyl-6-[(3-formyl-2,4-dihydroxy-6-methylbenzoyloxy)methyl]-2,4-dihydroxybenzoate
methyl 3,5-dimethoxy-2-[4-methoxy-5-oxo-3-(prop-1-en-1-yl)-2,7-dioxabicyclo[4.1.0]hept-3-ene-6-carbonyl]benzoate
10-hydroxy-5-methyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzo[h]chromen-4-one
(2s)-2-amino-4-{[(1r)-1-carboxy-2-{[cyano(1h-indol-3-yl)methyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid
C18H20N4O5S (404.11543500000005)
6-chloro-3-(4-hydroxy-3-methoxyphenyl)-5-methoxy-2-methyl-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one
(4r)-5,7-dihydroxy-8-[3-(4-hydroxyphenyl)propanoyl]-4-phenyl-3,4-dihydro-1-benzopyran-2-one
1',5-dihydroxy-7'-methoxy-3',7-dimethyl-[2,2'-binaphthalene]-1,4,5',8'-tetrone
(1s,3r,3's,4's,6's)-3',4',9-trihydroxy-6'-methyl-5,10-dioxo-3,4-dihydrospiro[naphtho[2,3-c]pyran-1,2'-oxan]-3-ylacetic acid
(e)-5,5'-dihydroxy-4,4'-dimethoxy-7,7'-dimethyl-[2,2'-binaphthalenylidene]-1,1'-dione
8,8'-dihydroxy-4,4'-dimethoxy-6,6'-dimethyl-[2,2'-binaphthalenylidene]-1,1'-dione
(z)-8,8'-dihydroxy-4,4'-dimethoxy-6,6'-dimethyl-[2,2'-binaphthalenylidene]-1,1'-dione
(e)-8,8'-dihydroxy-4,4'-dimethoxy-6,6'-dimethyl-[2,2'-binaphthalenylidene]-1,1'-dione
2-[(5r)-5-[(2e)-but-2-en-1-yl]-5-methyl-4-oxofuran-2-yl]-1,8-dihydroxy-3-methylanthracene-9,10-dione
(1,4-dihydroxy-6-methoxy-3-oxo-1h-2-benzofuran-5-yl)methyl 2-hydroxy-4-methoxy-3,6-dimethylbenzoate
4-chloro-6-(2,4-dichloro-3-hydroxy-5-propylphenoxy)-5-propylbenzene-1,3-diol
C18H19Cl3O4 (404.03488640000006)
6-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-5-hydroxy-8-methoxy-2-methylbenzo[g]chromen-4-one
(2r,3s)-6-chloro-3-(4-hydroxy-3-methoxyphenyl)-5-methoxy-2-methyl-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one
(4r)-7-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-5-[2-(4-hydroxyphenyl)ethenyl]-3,4-dihydro-1-benzopyran-2-one
(2s,3r,4s,5s,6r)-2-{[2-(3,5-dihydroxyphenyl)-1-benzofuran-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
5'-[(2-hydroxyphenyl)methyl]-5'-(methylsulfanyl)-7,7a-dihydro-3h-spiro[1-benzothiophene-2,2'-pyrazine]-3',6',7-triol
C19H20N2O4S2 (404.08644400000003)